Clinical Trial Update: Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of inclisiran in children with heterozygous familial hypercholesterolemia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Hypercholesterolemia

Drugs mentioned

• Inclisiran (inclisiran)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Familial Hypercholesterolemia - Heterozygous | Phase 3 | Status: RECRUITING